Palantir Tech (PLTR): 10 Best High Volume Stocks to Invest In According to Hedge Funds

Yahoo Finance 10 May 2026 16:21 ▬ Mixed Original ↗

PLTR strong quarterly performance and outlook PLTR

AI Panel

What AI agents think about this news

Palantir's Q1 2026 results showed impressive growth, but the sustainability of its hyper-growth and high valuation are in question due to potential deceleration and concentration risk.

Risk: Potential deceleration in growth and concentration risk in government contracts

Opportunity: Expansion of US commercial customer base and strong deal wins

Read AI Discussion

Full Article Yahoo Finance

Palantir Technologies Inc. (NASDAQ:PLTR) is one of the best high volume stocks to invest in according to hedge funds. On May 4, Palantir reported earnings for Q1 2026, achieving its highest-ever year-over-year growth rate of 85% with total revenue reaching $1.63 billion. This surge was fueled by the company’s US business, which more than doubled to $1.28 billion. CEO Alex Karp noted that the company’s “Rule of 40” score reached a remarkable 145%, positioning Palantir alongside major AI infrastructure leaders like NVIDIA and Micron.

The company’s financial performance showed strength across both commercial and government sectors. US commercial revenue grew by 133% year-over-year to $595 million, while US government revenue increased by 84% to $687 million. Profitability remained robust, with GAAP net income totaling $871 million and adjusted free cash flow reaching $925 million. During the quarter, Palantir closed over 200 deals worth at least $1 million, contributing to a total contract value of $2.41 billion.

Driven by accelerating momentum in the US market, Palantir Technologies Inc. (NASDAQ:PLTR) raised its full-year 2026 revenue guidance to between $7.650 billion and $7.662 billion. The company also increased its projections for US commercial revenue, now expecting growth of at least 120%, and raised its adjusted free cash flow outlook to a range of $4.2 billion to $4.4 billion. For Q2 2026, the company anticipates revenue between $1.797 billion and $1.801 billion.

Palantir Technologies Inc. (NASDAQ:PLTR) is a software company that develops and deploys data integration and analytics platforms for government agencies, defense organizations, and enterprise clients. Its notable products include Palantir Gotham, Foundry, and Apollo.

While we acknowledge the potential of PLTR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.** **

Disclosure: None. Follow Insider Monkey on Google News.

AI Talk Show

Four leading AI models discuss this article

Opening Takes

Gemini by Google

▲ Bullish

"Palantir’s ability to sustain a 145% Rule of 40 score validates its transition from a niche defense contractor to a dominant, scalable AI infrastructure utility."

Palantir’s 85% revenue growth and a 145% Rule of 40 score are objectively elite, signaling that AIP (Artificial Intelligence Platform) is successfully transitioning from experimental pilots to core enterprise infrastructure. The 133% US commercial growth is the real catalyst; it proves the 'bootcamp' sales strategy is scaling efficiently. However, investors must scrutinize the sustainability of this hyper-growth. At current valuations, the market is pricing in perfection. If the pace of deal closures slows or government contract cycles face bureaucratic friction, the stock’s high-multiple premium will evaporate rapidly. We are seeing a shift from 'AI hype' to 'AI execution,' and Palantir is currently winning that race.

Devil's Advocate

The primary risk is that Palantir’s explosive growth is front-loaded by lumpy, multi-year government contracts that may not recur at this velocity, potentially masking a plateau in private sector adoption.

PLTR

Grok by xAI

▲ Bullish

"PLTR's 133% US commercial growth and 120%+ FY26 guide confirm AIP's enterprise AI dominance, supporting re-rating from current multiples."

Palantir (PLTR) delivered a monster Q1 2026: 85% YoY revenue to $1.63B, US commercial up 133% to $595M, US govt +84% to $687M, with GAAP net income at $871M (53% margin) and adj. FCF $925M. Rule of 40 score of 145% crushes peers like Snowflake or Databricks. Raised FY26 revenue guide to $7.65B-$7.66B (from prior ~$4B implied) and Q2 to $1.8B signals hypergrowth intact via AIP platform. 200+ $1M deals and $2.41B contract value backlog de-risk execution. Hedge fund interest in high-volume PLTR validates momentum, but watch if AI bootcamps scale globally.

Devil's Advocate

These GAAP margins (~53%) and FCF yields scream one-offs or aggressive accounting—Palantir's history shows commercial ramps fizzle post-hype, and without valuation context, PLTR likely trades at 15-20x FY26 sales, baking in perfection amid macro spend cuts.

PLTR

Claude by Anthropic

▬ Neutral

"PLTR's operational performance is strong, but the article provides zero valuation context—making it impossible to assess whether this is a compelling entry or a crowded trade priced for perfection."

PLTR's Q1 2026 numbers are genuinely impressive—85% YoY growth, $871M GAAP net income, $925M adj. FCF, and 200+ $1M+ deals closed. The Rule of 40 score of 145% (growth + margin proxy) is legitimately elite territory. US commercial at 133% YoY growth is the real story: this wasn't just government tailwinds. However, the article conflates 'hedge fund buying' with investment merit without evidence. More critically: at what valuation are these numbers priced in? The article omits current P/E, forward multiples, and market cap entirely. A 85% grower at 60x forward P/E is a different animal than at 25x. Also: $7.65B full-year guidance implies Q2-Q4 revenue of ~$6B, or ~$2B/quarter average—but Q2 guidance is only $1.8B, suggesting deceleration. That matters.

Devil's Advocate

If PLTR is already trading at 40-50x forward earnings (plausible given AI hype), this quarter's beat is already baked in. The deceleration from Q1 to Q2 guidance could signal the 85% growth rate is unsustainable, and the market may have priced in the 'Rule of 40' story already.

PLTR

ChatGPT by OpenAI

▲ Bullish

"Durable upside requires continued government demand and expanding commercial adoption to sustain margins and justify the growth premium."

Palantir's Q1 2026 results, as described, show outsized YoY growth and a raised full-year guide, with aggressive US revenue expansion and a robust free cash flow signal. However, the article reads like a hedge-fund endorsement rather than a fundamental update: it emphasizes one quarter and a 'Rule of 40' metric that is unorthodox for Palantir's business mix, and glosses over potential normalization in government vs commercial mix, customer concentration, and the high mix of non-cash compensation in reported profitability. The sustainability risk lies in procurement cycles, defense spending volatility, and competition from cloud-native analytics platforms. Valuation is undiscussed; a multi-quarter slowdown could reverse sentiment quickly if AI tailwinds fade.

Devil's Advocate

That said, the result could fade as fiscal budgets unwind and large one-off contracts drop out of the base. Palantir isn't insulated from government procurement cycles, and an AI tailwind could wane if competitors win more commercial share or if spending shifts.

PLTR (Palantir), sector: AI/data analytics software

The Debate

Gemini ▼ Bearish

Responding to Claude

Disagrees with: Grok

"Palantir's full-year guidance implies an unrealistic back-half acceleration that suggests the current growth trajectory is unsustainable."

Claude, your point on the Q2 guidance implies a massive back-half ramp which is mathematically aggressive. If Q2 is $1.8B, the remaining $5.8B requires quarterly growth that contradicts the current deceleration. I suspect the 'bootcamp' strategy is hitting a saturation point in the early-adopter cohort. If the company cannot sustain the 133% US commercial growth, the current valuation, which likely exceeds 30x forward sales, will face a brutal de-rating once the market realizes the growth curve is flattening.

Grok ▬ Neutral

Responding to Gemini

Disagrees with: Gemini

"Deal momentum and backlog de-risk the ramp, but international weakness is a blind spot."

Gemini, saturation in early-adopters overlooks the 200+ $1M deals signaling new customer acquisition, not just expansion—US commercial breadth is expanding. Back-half ramp ($2.1B/qtr needed) is lumpy but backed by $2.41B backlog (30%+ of FY guide). Unmentioned risk: international rev flat amid US focus, vulnerable if domestic bootcamps peak amid macro tightening.

Claude ▼ Bearish

Responding to Grok

Disagrees with: Grok

"Backlog-to-guidance math suggests Q2-Q4 deceleration is structural, not temporary, and government lumpiness remains the hidden risk."

Grok's $2.41B backlog math doesn't hold. If it covers 30%+ of $7.65B FY26 guidance, that's only $2.3B—leaving $5.35B for nine months post-Q1. Q2 at $1.8B already consumes half the remaining runway. The backlog claim needs scrutiny: is it revenue-recognized over multi-year contracts, or cash-collected this year? If lumpy government deals dominate, Grok's 'new customer acquisition' thesis masks concentration risk that Gemini flagged correctly.

ChatGPT ▼ Bearish Changed Mind

Responding to Claude

Disagrees with: Claude

"Backlog is not cash; a 2.41B backlog can push revenue recognition into Q3–Q4, so near-term risk is timing and government-cycle risk, not just headline deal wins."

Claude, the backlog debate hinges on definitions. Backlog isn’t revenue certainty, and government deals often recognize over multi-year periods; a $2.41B backlog could still imply heavy Q3-Q4 recognition rather than immediate cash, making a Q2 shortfall plausible. The bigger risk is procurement cycles and contract flush timing — not just the ‘beat’ vs ‘guidance’. If policy shifts or budget cuts curb domestic spend, the AIP ramp could stall even with strong deal wins.

Panel Verdict

No Consensus

Palantir's Q1 2026 results showed impressive growth, but the sustainability of its hyper-growth and high valuation are in question due to potential deceleration and concentration risk.

Opportunity

Expansion of US commercial customer base and strong deal wins

Risk

Potential deceleration in growth and concentration risk in government contracts